[{"address1": "5005 McConnell Avenue", "city": "Los Angeles", "state": "CA", "zip": "90066", "country": "United States", "phone": "310 665 2928", "fax": "310 665 2963", "website": "https://www.armatapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. Deborah L. Birx M.D.", "age": 67, "title": "CEO & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 554998, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David D. House", "age": 41, "title": "Senior VP of Finance & Principal Financial Officer", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 352231, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pierre  Kyme Ph.D.", "age": 47, "title": "Chief Business Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 733062, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Hubbard", "title": "Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bani  Tchekanova Ph.D.", "title": "Head of Regulatory Strategy & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.ampliphibio.com/phoenix.zhtml?c=84981&p=irol-stockquote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.64, "open": 6.65, "dayLow": 6.435, "dayHigh": 6.95, "regularMarketPreviousClose": 6.64, "regularMarketOpen": 6.65, "regularMarketDayLow": 6.435, "regularMarketDayHigh": 6.95, "payoutRatio": 0.0, "beta": 1.306, "forwardPE": -4.2675157, "volume": 59654, "regularMarketVolume": 59654, "averageVolume": 66645, "averageVolume10days": 46480, "averageDailyVolume10Day": 46480, "bid": 6.84, "ask": 6.94, "bidSize": 300, "askSize": 1000, "marketCap": 243926256, "fiftyTwoWeekLow": 0.9, "fiftyTwoWeekHigh": 16.34, "allTimeHigh": 1960000.0, "allTimeLow": 0.83, "priceToSalesTrailing12Months": 48.264, "fiftyDayAverage": 6.3524, "twoHundredDayAverage": 3.63985, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 406335936, "profitMargins": 0.0, "floatShares": 11028287, "sharesOutstanding": 36406905, "sharesShort": 222054, "sharesShortPriorMonth": 133987, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0061000003, "heldPercentInsiders": 0.69117, "heldPercentInstitutions": 0.02273, "shortRatio": 4.49, "shortPercentOfFloat": 0.020499999, "impliedSharesOutstanding": 36406905, "bookValue": -2.638, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -46901000, "trailingEps": -1.68, "forwardEps": -1.57, "lastSplitFactor": "1:14", "lastSplitDate": 1557446400, "enterpriseToRevenue": 80.399, "enterpriseToEbitda": -12.755, "52WeekChange": 2.270936, "SandP52WeekChange": 0.16255379, "quoteType": "EQUITY", "currentPrice": 6.7, "targetHighPrice": 15.0, "targetLowPrice": 9.0, "targetMeanPrice": 12.0, "targetMedianPrice": 12.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 14756000, "totalCashPerShare": 0.406, "ebitda": -31857000, "totalDebt": 177682000, "quickRatio": 0.111, "currentRatio": 0.121, "totalRevenue": 5054000, "revenuePerShare": 0.14, "returnOnAssets": -0.22202998, "grossProfits": -21044000, "freeCashflow": -25217250, "operatingCashflow": -27016000, "revenueGrowth": -0.61, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -6.70923, "financialCurrency": "USD", "symbol": "ARMP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 769440600000, "postMarketChangePercent": -0.59701437, "postMarketPrice": 6.66, "postMarketChange": -0.03999996, "regularMarketChange": 0.059999943, "regularMarketDayRange": "6.435 - 6.95", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 66645, "fiftyTwoWeekLowChange": 5.7999997, "fiftyTwoWeekLowChangePercent": 6.444444, "marketState": "CLOSED", "shortName": "Armata Pharmaceuticals, Inc.", "longName": "Armata Pharmaceuticals, Inc.", "regularMarketChangePercent": 0.90361357, "regularMarketPrice": 6.7, "corporateActions": [], "postMarketTime": 1769815404, "regularMarketTime": 1769806800, "exchange": "ASE", "messageBoardId": "finmb_84546611", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "earningsTimestamp": 1762981200, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.68, "epsForward": -1.57, "epsCurrentYear": -1.54, "priceEpsCurrentYear": -4.3506494, "fiftyDayAverageChange": 0.34759998, "fiftyDayAverageChangePercent": 0.054719474, "twoHundredDayAverageChange": 3.06015, "twoHundredDayAverageChangePercent": 0.8407352, "priceToBook": -2.5398028, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Armata Pharmaceuticals Inc.", "nameChangeDate": "2026-01-30", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "fiftyTwoWeekRange": "0.9 - 16.34", "fiftyTwoWeekHighChange": -9.64, "fiftyTwoWeekHighChangePercent": -0.5899633, "fiftyTwoWeekChangePercent": 227.0936, "dividendDate": 1557446400, "displayName": "Armata Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]